SCHEMBL25582795

C#CCOCCOCCOCCOCCC(=O)N1C[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@H]2CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CCN)NC2=O)[C@@H](C)O)[C@@H](C)CC)[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@H]2CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CCN)NC2=O)[C@@H](C)O)[C@@H](C)CC)C1

nearest known ligand 0.62

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	KDM1A	O60341	3/20	0.62

▸	RCOR1	Q9UKL0	2/20	0.62

▸	TERF2IP	Q9NYB0	4/20	0.42

▸	PRLHR	P49683	2/20	0.38

▸	EGFR	P00533	1/20	0.37

▸	LCK	P06239	1/20	0.37

▸	NPY1R	P25929	2/20	0.36

▸	NPY2R	P49146	2/20	0.36

▸	NPY4R	P50391	2/20	0.36

▸	NPY5R	Q15761	2/20	0.36

▸	HKDC1	Q2TB90	1/20	0.36

▸	KRAS	P01116	4/20	0.36

▸	LDHB	P07195	2/20	0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL25582796	0.97	KDM1A (0.58)	KDM1ARCOR1TERF2IPPRLHREGFR
SCHEMBL25582804	0.95	KDM1A (0.66)	KDM1ARCOR1TERF2IPPRLHREGFR
SCHEMBL25582800	0.94	KDM1A (0.64)	KDM1ARCOR1TERF2IPEGFRLCK
SCHEMBL26181836	0.91	KDM1A (0.68)	KDM1ARCOR1TERF2IPEGFRLCK
SCHEMBL25582809	0.90	KDM1A (0.67)	KDM1ARCOR1TERF2IPEGFRLCK
SCHEMBL26181835	0.90	KDM1A (0.65)	KDM1ARCOR1TERF2IPNPY1RNPY2R
SCHEMBL26181847	0.89	KDM1A (0.67)	KDM1ARCOR1TERF2IPEGFRLCK
SCHEMBL25582813	0.88	KDM1A (0.65)	KDM1ARCOR1TERF2IPEGFRLCK
SCHEMBL25582811	0.85	KDM1A (0.61)	KDM1ARCOR1TERF2IPEGFRLCK
SCHEMBL26181706	0.83	KDM1A (0.78)	KDM1ARCOR1TERF2IPLDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230165970-A1	COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS	CIDARA THERAPEUTICS, INC.	2023-06-01	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20230165970-A1	COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS	FCGR3B, FCGR1A, FCGR2A	KDM1A 4789/4885RCOR1 4863/4885TERF2IP 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.